The name Clay Siegall might not be too familiar to the majority of the population, but this extraordinary guy has brought many innovative things to cancer research. This man is a doctor, a scientist and a businessman. When it comes to fighting cancer, this fellow is known as Dr. Clay Siegall, and he has left a lasting-impact on society. Dr. Siegall had an up-close-and-personal account with cancer as his father became ill from this dangerous disease. Siegall was a college student at the time, but he remembered just how harsh cancer treatments were back in the day. Everything from radical surgeries to amputations were taking place, but there had to be a more efficient way of winning this battle.
After earning a Ph.D in Genetics as well as attaining an undergraduate degree in Biology, Siegall went to work. He has worked for a number of prominent industry names such as Bristol Myers Squibb and the National Institute of Health. In 1998, Dr. Siegall made his dream come true via Seattle Genetics. This biotech-oncology company started-out as a tiny startup company of only a handful of staff members. Seattle Genetics was focused more on research and drug development back in the day. Funding the company was quite difficult, but this small list of staff members found a solution to pull the company out of the hole. Dr. Siegall was forced to sell the company’s international-commercial rights just to stay afloat, but today is a new day. As of now, Seattle Genetics sits at the top of cancer research thanks to it’s proprietary drugs.
Owning patents as well as owning international-commercial rights is what you have to do to make it to the top. The company now has a Swiss-office overseas, which handles the company’s international marketing. The future is looking much brighter than before and Dr. Clay Siegall is the reason why.